Name: Frenzy behind the Facade: A True-to-Life Portrayal of the Pharmaceutical Industry (en Inglés)
Price: 87.57 PEN
Availability: InStock
Author: Newmiller, Richard F.
ISBN: 9781484942185

portada Frenzy behind the Facade: A True-to-Life Portrayal of the Pharmaceutical Industry (en Inglés)

Formato

Libro Físico

Autor

Richard F. Newmiller

Editorial

Createspace Independent Publishing Platform

Idioma

Inglés

N° páginas

248

Encuadernación

Tapa Blanda

Dimensiones

22.9 x 15.2 x 1.3 cm

Peso

0.34 kg.

ISBN13

9781484942185

Categorías

Ficción literaria

Frenzy behind the Facade: A True-to-Life Portrayal of the Pharmaceutical Industry (en Inglés)

Richard F. Newmiller (Autor) · Createspace Independent Publishing Platform · Tapa Blanda

Libro Nuevo

S/ 87,57

S/ 175,14

Ahorras: S/ 87,57

50% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Lunes 12 de Agosto y el Miércoles 21 de Agosto.

Lo recibirás en cualquier lugar de Perú entre 2 y 5 días hábiles luego del envío.

Reseña del libro "Frenzy behind the Facade: A True-to-Life Portrayal of the Pharmaceutical Industry (en Inglés)"

William Casper takes on the biggest professional challenge of his life, the turnaround of Pharmacy Healthcare Company, an over-the-counter drug manufacturer. Even his industry peers recommend against him assuming the role of president and CEO-the company is headed for certain bankruptcy. Casper has to prevail against falling revenues, runaway expenses, as well as greedy, opportunistic distributors. At the same time, the company is dealing with noncompliance observations and warning letters issued after multiple critical inspections by the FDA. For the company to survive, Casper also has to identify and plug a leak in his organization and bring a new and highly profitable prescription drug to market. Although a novel, the events portrayed parallel real-life daily regulatory and compliance encounters throughout the pharmaceutical supply chain-a look behind the facade. It's no wonder the list of unavailable or limited-supply drug products continues to grow. Excerpts: "In all honesty, I'm surprised every day that we're able to manufacture a quality product using this facility." "Creating mistrust between the chairman and the CEO is such a deviant and divisive act." "We are just like a hundred other manufacturers out there, trying to survive in a marketplace where margins are being squeezed and the regulations are ever increasing." "The FDA has done their job, now we need to do ours." "You were right. I spoke on the phone with him last night, and he is complicit. As suggested, he will be working with PHC in exchange for leniency."